Analysis of the availability and accessibility of hypotensive drugs recommended for use in pregnant women
Aim: To verify the availability and accessibility of hypotensive drugs recommended for use in pregnant women. Materials and methods. The analytical study of normative documents and State Registers of drugs in Russia, the US and the EU has been carried out. Results. It has been established that for the treatment of pregnant women with hypertension of mild and moderate severity it is advisable to use a fairly represented on the Russian market and available: agonists A2 adrenoreceptor-methyldopa (Dopegita); beta-blockers, selective (bisoprolol, metoprolol); blockers slow calcium channels – nifedipine, verapamil.
About Authors (Correspondence):
Konyshko N.A. – candidate of medical sciences, assistant professor of the faculty therapy chair, e-mail: Nkonyshko@yandex.ru
Krikova A.V. – doctor of medical sciences, assistant professor of the pharmacy management and economic chair, е-mail: email@example.com